The decreasing costs of Next Generation Sequencing (NGS) prompted the first whole-exome sequencing (WES) which allowed to detect variants affecting function in HAE-nC1-INH patients in angiopoietin (ANGPT1) and plasminogen (PLG) genes (18, 19). The gene discussed is COL18A1; the disease is hereditary angioedema.